Ultrasound-guided aspiration with sclerosing therapy in ovarian cyst

Y. C. Yang, J. M. Yang, H. S. Chen, K. G. Wang

Research output: Contribution to journalArticle

Abstract

Background: Successful treatment of ovarian cyst by aspiration has been reported, especially in cases of simple cyst presumed to be benign. Sotradecol is a mild sclerosing agent used for the treatment of small uncomplicated varicose veins. Aspiration followed by sclerosing therapy with Sotradecol might be a reasonable approach for ovarian cyst in selected cases. Materials and Methods: Samples of 70 cyst fluids were collected for analysis from 62 patients undergoing laparotomy. Estradiol (E2) and CA-125 levels and cytologic examination results were correlated with the nature of the cyst. Another 51 consecutive patients with unilocular cysts that had been present for over three months were enrolled for this study. The cysts were aspirated and injected with Sotradecol under ultrasound guidance. Results: Only 52% of cyst fluid had adequate cells for cytologic examination. All functional cysts had E2 levels of over 1,000 pg/mL. CA-125 levels in cyst fluid were not correlated with the nature of the cyst. Ultrasound-guided cyst aspiration with Sotradecol sclerosing therapy resulted in an overall success rate of 78.4%. On reflection, the failure rate could have been reduced to 2%. Conclusion: The examination of cyst aspirate was inadequate for identifying malignancy. Ultrasound-guided aspiration with Sotradecol sclerosing therapy is highly promising for the treatment of selected ovarian cysts.

Original languageEnglish
Pages (from-to)194-200
Number of pages7
JournalJournal of Medical Ultrasound
Volume3
Issue number4
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Ovarian Cysts
Sodium Tetradecyl Sulfate
Cysts
Cyst Fluid
Therapeutics
Sclerosing Solutions
Varicose Veins
Laparotomy
Estradiol

Keywords

  • ovarian cyst aspiration
  • sclerosing therapy
  • Sotradecol

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Ultrasound-guided aspiration with sclerosing therapy in ovarian cyst. / Yang, Y. C.; Yang, J. M.; Chen, H. S.; Wang, K. G.

In: Journal of Medical Ultrasound, Vol. 3, No. 4, 1995, p. 194-200.

Research output: Contribution to journalArticle

Yang, Y. C. ; Yang, J. M. ; Chen, H. S. ; Wang, K. G. / Ultrasound-guided aspiration with sclerosing therapy in ovarian cyst. In: Journal of Medical Ultrasound. 1995 ; Vol. 3, No. 4. pp. 194-200.
@article{b06c44311c794bb9ac16b6da9b70fd4c,
title = "Ultrasound-guided aspiration with sclerosing therapy in ovarian cyst",
abstract = "Background: Successful treatment of ovarian cyst by aspiration has been reported, especially in cases of simple cyst presumed to be benign. Sotradecol is a mild sclerosing agent used for the treatment of small uncomplicated varicose veins. Aspiration followed by sclerosing therapy with Sotradecol might be a reasonable approach for ovarian cyst in selected cases. Materials and Methods: Samples of 70 cyst fluids were collected for analysis from 62 patients undergoing laparotomy. Estradiol (E2) and CA-125 levels and cytologic examination results were correlated with the nature of the cyst. Another 51 consecutive patients with unilocular cysts that had been present for over three months were enrolled for this study. The cysts were aspirated and injected with Sotradecol under ultrasound guidance. Results: Only 52{\%} of cyst fluid had adequate cells for cytologic examination. All functional cysts had E2 levels of over 1,000 pg/mL. CA-125 levels in cyst fluid were not correlated with the nature of the cyst. Ultrasound-guided cyst aspiration with Sotradecol sclerosing therapy resulted in an overall success rate of 78.4{\%}. On reflection, the failure rate could have been reduced to 2{\%}. Conclusion: The examination of cyst aspirate was inadequate for identifying malignancy. Ultrasound-guided aspiration with Sotradecol sclerosing therapy is highly promising for the treatment of selected ovarian cysts.",
keywords = "ovarian cyst aspiration, sclerosing therapy, Sotradecol",
author = "Yang, {Y. C.} and Yang, {J. M.} and Chen, {H. S.} and Wang, {K. G.}",
year = "1995",
language = "English",
volume = "3",
pages = "194--200",
journal = "Journal of Medical Ultrasound",
issn = "0929-6441",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "4",

}

TY - JOUR

T1 - Ultrasound-guided aspiration with sclerosing therapy in ovarian cyst

AU - Yang, Y. C.

AU - Yang, J. M.

AU - Chen, H. S.

AU - Wang, K. G.

PY - 1995

Y1 - 1995

N2 - Background: Successful treatment of ovarian cyst by aspiration has been reported, especially in cases of simple cyst presumed to be benign. Sotradecol is a mild sclerosing agent used for the treatment of small uncomplicated varicose veins. Aspiration followed by sclerosing therapy with Sotradecol might be a reasonable approach for ovarian cyst in selected cases. Materials and Methods: Samples of 70 cyst fluids were collected for analysis from 62 patients undergoing laparotomy. Estradiol (E2) and CA-125 levels and cytologic examination results were correlated with the nature of the cyst. Another 51 consecutive patients with unilocular cysts that had been present for over three months were enrolled for this study. The cysts were aspirated and injected with Sotradecol under ultrasound guidance. Results: Only 52% of cyst fluid had adequate cells for cytologic examination. All functional cysts had E2 levels of over 1,000 pg/mL. CA-125 levels in cyst fluid were not correlated with the nature of the cyst. Ultrasound-guided cyst aspiration with Sotradecol sclerosing therapy resulted in an overall success rate of 78.4%. On reflection, the failure rate could have been reduced to 2%. Conclusion: The examination of cyst aspirate was inadequate for identifying malignancy. Ultrasound-guided aspiration with Sotradecol sclerosing therapy is highly promising for the treatment of selected ovarian cysts.

AB - Background: Successful treatment of ovarian cyst by aspiration has been reported, especially in cases of simple cyst presumed to be benign. Sotradecol is a mild sclerosing agent used for the treatment of small uncomplicated varicose veins. Aspiration followed by sclerosing therapy with Sotradecol might be a reasonable approach for ovarian cyst in selected cases. Materials and Methods: Samples of 70 cyst fluids were collected for analysis from 62 patients undergoing laparotomy. Estradiol (E2) and CA-125 levels and cytologic examination results were correlated with the nature of the cyst. Another 51 consecutive patients with unilocular cysts that had been present for over three months were enrolled for this study. The cysts were aspirated and injected with Sotradecol under ultrasound guidance. Results: Only 52% of cyst fluid had adequate cells for cytologic examination. All functional cysts had E2 levels of over 1,000 pg/mL. CA-125 levels in cyst fluid were not correlated with the nature of the cyst. Ultrasound-guided cyst aspiration with Sotradecol sclerosing therapy resulted in an overall success rate of 78.4%. On reflection, the failure rate could have been reduced to 2%. Conclusion: The examination of cyst aspirate was inadequate for identifying malignancy. Ultrasound-guided aspiration with Sotradecol sclerosing therapy is highly promising for the treatment of selected ovarian cysts.

KW - ovarian cyst aspiration

KW - sclerosing therapy

KW - Sotradecol

UR - http://www.scopus.com/inward/record.url?scp=0029550304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029550304&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029550304

VL - 3

SP - 194

EP - 200

JO - Journal of Medical Ultrasound

JF - Journal of Medical Ultrasound

SN - 0929-6441

IS - 4

ER -